CHRW Stock Forecast & Price Target

C.H. Robinson Worldwide is viewed positively because 3Q adj. EPS of $1.80 beat estimates, revenue reached $5.36B, and gross profit expanded despite a 10.4% y/y reduction in headcount, showing strong operating leverage. Its core brokerage engine is gaining share, with NAST shipments up 3.5% vs. a 0.3% decline in the Cass index and 14 consecutive quarters of outperformance, while Global Forwarding delivered 15% y/y gross profit growth and meaningful margin expansion. The outlook is further supported by lean AI productivity gains, disciplined pricing, and potential synergy from RXO integration, even as elevated claims expense remains a near-term overhang.

C.H. Robinson Worldwide is viewed negatively because its core NAST gross margin of 13.5% missed estimates, and despite +3.5% volumes outpacing the market, 4Q gross profit and EBIT are expected to step down sequentially as spot and buy rates tighten and volumes ease. Management’s decision to leave the FY EBIT guide at $964MM-$1040MM, even with consistent outperformance, has heightened concern that underlying demand and pricing remain fragile while investor expectations stay elevated. The outlook is further pressured by skepticism around the RXO deal, where management offered limited clarity on customer overlap, and by broader risks from pricing pressure in Global Forwarding and NAST, a softening macro backdrop, and possible insurance renewal headwinds in '27.